The NMS Act Cap 207 states that the corporation shall advise the Ministry of Health, Ministry of Finance, Planning and Economic Development, Ministry of Local Government and National Drug Authority on essential issues relating to the state of the Corporation and its future development as well as to...
The World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) met in Geneva from 16 to 20 October 2017.Dr Suzanne R. Hill, acting Assistant Director of the Health Systems and Innovation Cluster and Director of the Department of Essential Medicines and...
The WHA 54.11 WHO medicines strategy acknowledged the four main objectives of WHO��s medicines strategy, namely, to frame and implement policy; to ensure access; to ensure quality, safety and efficacy; and to promote rational use of medicines. The WHO medicines strategy 2004-2007 presents the strate...
The thirty-seventh meeting of the WHO Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 16 to 20 November 2015. Mr Cornelis de Joncheere, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. He welcomed all participants on beh...
The Essential Medicines and Health Supplies List for�Uganda (EMHSLU) 2023 reflects the policy of the�Ministry of Health, for the appropriate procurement�of safe and efficacious essential medicines, health and�laboratory supplies in public institutions.�The EMHSLU 2023 was compiled based on�recommend...
Procurement planning is an annual exercise conducted by Health Facilities (HFs) countrywide with technical assistance from National Medical Stores (NMS) and under the supervision of Ministry of Health (MoH) with the objective of quantifying or determining facility pharmaceutical needs for the next f...
The World Health Organization (WHO), the United Nations Children��s Fund (UNICEF) and many other organizations are involved in the procurement of pharmaceutical products. In particular, the supply of pharmaceutical products used in the treatment of human immunodeficiency virus/acquired immunodeficie...
In June 2010, the Ugandan Ministry of Health (MOH) with support from the United States Agency for International Development (USAID)-funded Securing Ugandans�� Right to Essential Medicines (SURE) Program, collected data for the 2010 Pharmaceutical Sector Report. This report presents the findings of t...
The Ministry of Health (MOH), through the Department of Pharmaceuticals and Natural Medicines (DPNM), executed the national integrated quantification for all Essential Medicines and Health Supplies (EMHS) for the financial year 2024/25.�As a result, the total commodity need for routine service deliv...
A standard operating procedure (SOP) is a set of systematic instructions compiled by an organization to help workers carry out complex routine operations. SOPs aim to achieve efficiency, quality output and uniformity of performance, while reducing miscommunication and failure to comply with regulati...
The organizations and agencies of the United Nations system and international and nongovernmental organizations are called upon to respond to an increasing number of largescale emergencies and disasters, many of which pose a serious threat to health. Much of the assistance provided in such situation...
National quantification of EMHLS is an annual exercise conducted by NMS under the direct supervision of MoH, and the exercise is intended to provide all public sector players/stakeholder in the health sector with feedback about facility needs in accordance with the NMS Act Cap 207 that states in par...
The Ministry of Health (MOH), in collaboration with the U.S. Agency for International Development (USAID), the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund), the USAID Global Health Supply Chain-Procurement and Supply Management (GHSC-PSM) project, and the USAID Uganda Health...
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 14 to 18 October 2013. Dr M.-P. Kieny, Assistant Director-General of Health Systems and Innovation at the World Health Organization (WHO), welcomed participants on behalf of the Director-General. Dr Kieny t...
Problems related to the safety and quality of drugs exist in many places around the world today, in developing and developed countries alike. Some incidents have ended in tragedy, often with children as the victims. They are caused by the use of drugs containing toxic substances or impurities, drugs...
The Ministry of Health (MoH) Department of Pharmaceuticals and Natural Medicines (DPNM) coordinated the first integrated quantification process for Essential Medicines and Health Supplies (EMHS) for the public and PNFP sector for Financial Years 2023/24 - 2025/26.�Quantification is a core component...
The schedue provides for control of 98 psychotropical substances which are assigned to one of the four schedues.
The Fifty-third meeting of the World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) took place in Geneva, Switzerland, from 22 to 26 October 2018. Participants of the meeting were welcomed by Dr Mariângela Simão, Assistant Director-General, Acces...
A drug and therapeutics committee (DTC) provides such a forum, allowing all the relevant people to work together to improve health care delivery, whether in hospitals or other health facilities. In many developed countries a well functioning DTC has been shown to be very effective in addressing drug...
The thirty-eighth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 14 to 18 November 2016. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. She welcomed all...
